Back

PROTAC molecule-mediated SpCas9 protein degradation for precise genome editing

Sun, S.; Sun, R.; Tan, M.; Kip, M.; Yang, X.; Pang, B.

2025-01-07 biochemistry
10.1101/2025.01.07.631496 bioRxiv
Show abstract

CRISPR (clustered regularly interspaced short palindromic repeats) technology has revolutionized both fundamental research and genomic medicine. The need for precise control of SpCas9-based CRISPR genome editing has led to the development of various strategies to regulate Cas9 activity, aiming to minimize off-target effects. Proteolysis-targeting chimeras (PROTACs) use the ubiquitin-proteasome system to selectively degrade target proteins. Here, we developed CASPROTAC 6, a reversible and cell-permeable PROTAC degrader that directly targets SpCas9 proteins for degradation. The CASPROTAC 6 molecule was derived by linking a known SpCas9 binder BRD7087 with an S-substituted Lenalidomide cereblon (CRBN) ligand via a six-carbon alkyl linker. Our data show that CASPROTAC 6 is a broad-spectrum degrader of SpCas9 and variants such as dCas9 and Cas9 nickases. CASPROTAC 6 degrades SpCas9 and the SpCas9-guide RNA complex via the proteasome system by approximately 50%. As a result, CASPROTAC 6 effectively enhanced the precision of CRISPR/Cas9-mediated genome editing by increasing target specificity. CASPROTAC 6 may serve as modulators of CRISPR/SpCas9-associated nucleases, enabling precise genome editing while reducing off-target effects and enhancing biosafety.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
The CRISPR Journal
○ 39 papers in training set
Top 0.1%
18.6%
Similar papers in this journal
2
Nucleic Acids Research
◐ 1281 papers in training set
Top 2%
7.9%
Similar papers in this journal
3
Molecular Therapy - Nucleic Acids
○ 25 papers in training set
Top 0.1%
6.8%
Similar papers in this journal
4
ChemBioChem
○ 55 papers in training set
Top 0.2%
4.9%
Similar papers in this journal
5
ACS Chemical Biology
● 167 papers in training set
Top 0.6%
4.4%
Similar papers in this journal
6
Acta Biochimica et Biophysica Sinica
● 23 papers in training set
Top 0.1%
4.1%
7
Molecular Therapy Nucleic Acids
○ 39 papers in training set
Top 0.2%
3.2%
8
eLife
● 5828 papers in training set
Top 36%
3.2%
50% of probability mass above
9
Journal of Molecular Biology
○ 232 papers in training set
Top 1%
2.7%
10
International Journal of Biological Macromolecules
○ 76 papers in training set
Top 0.6%
2.5%
11
Science China Life Sciences
○ 29 papers in training set
Top 0.2%
2.1%
12
Scientific Reports
○ 3612 papers in training set
Top 49%
1.9%
13
Journal of Biological Chemistry
○ 690 papers in training set
Top 5%
1.9%
14
International Journal of Molecular Sciences
○ 494 papers in training set
Top 7%
1.9%
15
Nature Communications
○ 5641 papers in training set
Top 43%
1.9%
16
Biochemical Journal
● 91 papers in training set
Top 0.7%
1.7%
17
PLOS ONE
● 5266 papers in training set
Top 48%
1.5%
18
Molecular Therapy
○ 81 papers in training set
Top 1%
1.4%
19
The FEBS Journal
○ 93 papers in training set
Top 1%
1.1%
20
iScience
○ 1154 papers in training set
Top 26%
1.1%
21
Cells
○ 249 papers in training set
Top 5%
1.1%
22
Biochimie
○ 25 papers in training set
Top 0.5%
1.1%
23
Biochemical and Biophysical Research Communications
○ 84 papers in training set
Top 2%
0.8%
24
Chemical Science
● 73 papers in training set
Top 2%
0.8%
25
Antiviral Research
○ 50 papers in training set
Top 0.8%
0.6%
26
Open Biology
● 106 papers in training set
Top 2%
0.6%
27
Advanced Science
○ 286 papers in training set
Top 11%
0.6%
28
Bioscience Reports
● 27 papers in training set
Top 2%
0.6%
29
Methods
○ 34 papers in training set
Top 0.8%
0.6%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.